178 related articles for article (PubMed ID: 16480875)
1. Investigation of the mechanism of action of 3-(4-bromophenyl)-5-acyloxymethyl-2,5-dihydrofuran-2-one against Candida albicans by flow cytometry.
Vale-Silva LA; Buchta V; Vokurková D; Pour M
Bioorg Med Chem Lett; 2006 May; 16(9):2492-5. PubMed ID: 16480875
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity of lariciresinol derived from Sambucus williamsii and their membrane-active mechanisms in Candida albicans.
Hwang B; Cho J; Hwang IS; Jin HG; Woo ER; Lee DG
Biochem Biophys Res Commun; 2011 Jul; 410(3):489-93. PubMed ID: 21679690
[TBL] [Abstract][Full Text] [Related]
3. Antifungal mechanism of an antimicrobial peptide, HP (2--20), derived from N-terminus of Helicobacter pylori ribosomal protein L1 against Candida albicans.
Lee DG; Park Y; Kim HN; Kim HK; Kim PI; Choi BH; Hahm KS
Biochem Biophys Res Commun; 2002 Mar; 291(4):1006-13. PubMed ID: 11866466
[TBL] [Abstract][Full Text] [Related]
4. Fungicidal effect of antimicrobial peptide, PMAP-23, isolated from porcine myeloid against Candida albicans.
Lee DG; Kim DH; Park Y; Kim HK; Kim HN; Shin YK; Choi CH; Hahm KS
Biochem Biophys Res Commun; 2001 Mar; 282(2):570-4. PubMed ID: 11401498
[TBL] [Abstract][Full Text] [Related]
5. Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity.
Borate HB; Sawargave SP; Chavan SP; Chandavarkar MA; Iyer R; Tawte A; Rao D; Deore JV; Kudale AS; Mahajan PS; Kangire GS
Bioorg Med Chem Lett; 2011 Aug; 21(16):4873-8. PubMed ID: 21757344
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
Lignell A; Löwdin E; Cars O; Sjölin J
J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
[TBL] [Abstract][Full Text] [Related]
7. Antifungal 3,5-disubstituted furanones: From 5-acyloxymethyl to 5-alkylidene derivatives.
Senel P; Tichotová L; Votruba I; Buchta V; Spulák M; Kunes J; Nobilis M; Krenk O; Pour M
Bioorg Med Chem; 2010 Mar; 18(5):1988-2000. PubMed ID: 20153653
[TBL] [Abstract][Full Text] [Related]
8. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activity and mode of action of silver nano-particles on Candida albicans.
Kim KJ; Sung WS; Suh BK; Moon SK; Choi JS; Kim JG; Lee DG
Biometals; 2009 Apr; 22(2):235-42. PubMed ID: 18769871
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activity of artemisinin derivatives.
Galal AM; Ross SA; Jacob M; ElSohly MA
J Nat Prod; 2005 Aug; 68(8):1274-6. PubMed ID: 16124777
[TBL] [Abstract][Full Text] [Related]
11. Fungicidal effect and the mode of action of piscidin 2 derived from hybrid striped bass.
Sung WS; Lee J; Lee DG
Biochem Biophys Res Commun; 2008 Jul; 371(3):551-5. PubMed ID: 18445475
[TBL] [Abstract][Full Text] [Related]
12. Damage to the cytoplasmic membrane and cell death caused by lycopene in Candida albicans.
Sung WS; Lee IS; Lee DG
J Microbiol Biotechnol; 2007 Nov; 17(11):1797-804. PubMed ID: 18092463
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of local anesthetics against Candida species.
Pina-Vaz C; Rodrigues AG; Sansonetty F; Martinez-De-Oliveira J; Fonseca AF; Mårdh PA
Infect Dis Obstet Gynecol; 2000; 8(3-4):124-37. PubMed ID: 10968594
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antifungal susceptibility using flow cytometry.
Pina-Vaz C; Rodrigues AG
Methods Mol Biol; 2010; 638():281-9. PubMed ID: 20238277
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of synthetic di(hetero)arylamines based on the benzo[b]thiophene moiety.
Pinto E; Queiroz MJ; Vale-Silva LA; Oliveira JF; Begouin A; Begouin JM; Kirsch G
Bioorg Med Chem; 2008 Sep; 16(17):8172-7. PubMed ID: 18678498
[TBL] [Abstract][Full Text] [Related]
16. Flow Cytometry-Based Method To Detect Persisters in Candida albicans.
Chang W; Zhang M; Li Y; Lou H
Antimicrob Agents Chemother; 2015 Aug; 59(8):5044-8. PubMed ID: 26014939
[TBL] [Abstract][Full Text] [Related]
17. Citridones, new potentiators of antifungal miconazole activity, produced by Penicillium sp. FKI-1938. I. Taxonomy, fermentation, isolation and biological properties.
Fukuda T; Yamaguchi Y; Masuma R; Tomoda H; Omura S
J Antibiot (Tokyo); 2005 May; 58(5):309-14. PubMed ID: 16060382
[TBL] [Abstract][Full Text] [Related]
18. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.
Mai A; Rotili D; Massa S; Brosch G; Simonetti G; Passariello C; Palamara AT
Bioorg Med Chem Lett; 2007 Mar; 17(5):1221-5. PubMed ID: 17196388
[TBL] [Abstract][Full Text] [Related]
19. Tensidols, new potentiators of antifungal miconazole activity, produced by Aspergillus niger FKI-2342.
Fukuda T; Hasegawa Y; Hagimori K; Yamaguchi Y; Masuma R; Tomoda H; Omura S
J Antibiot (Tokyo); 2006 Aug; 59(8):480-5. PubMed ID: 17080684
[TBL] [Abstract][Full Text] [Related]
20. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
